Source - SMW
Exane BNP Paribas today downgrades its investment rating on AstraZeneca PLC (LON:AZN) to neutral (from outperform) and set its price target at 5200p.

Related Charts

AstraZeneca (AZN)

-150.00p (-3.36%)
delayed 18:15PM